/PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:... ...http://www.andhranews.net/Intl/Web/20-81.asp
At a time when the international regulatory bodies are trying to crack the whip on Indian pharma manufacturers for various reasons including... ...http://www.pharmabiz.com/NewsDetails.aspx?aid=82850&sid=1
Key benchmark indices fell for the second day in a row after the Economic Survey 2013-14 presented by Finance Minister Arun Jaitely as precursor to... ...http://www.business-standard.com/article/news-cm/sensex-drops-2-51-in-two-trading-sessions-ahead-of-budget-114070901173_1.html
Telmisartan, which is the generic version of Boehringer Ingelheim's Micardis, garnered annual sales of $ 250 million for the 12 month period ending... ...http://www.business-standard.com/content/b2b-pharma/glenmark-receives-usfda-approval-for-telmisartan-tablets-114070900982_1.html
US drug regulator termed Claris' facility as acceptable after the inspection ...http://www.business-standard.com/content/b2b-pharma/claris-lifesciences-facility-receives-usfda-s-positive-nod-114070900952_1.html
Miocon is pleased to introduce...